New strategies for improved tuberculosis vaccines (Old ID 23218)
Role
Principal Investigator
Description
Tuberculosis is a major global public health problem and continues to cause significant morbidity and mortality due to the low efficiency of the only licensed anti-tuberculosis vaccine, BCG. This project aims to produce novel, highly efficacious vaccination regimens against tuberculosis, especially pulmonary tuberculosis, which is currently the most difficult manifestation of infection to control. The results of this project have the potential to not only save millions of lives in the developing world but also to decrease socioeconomic burden of tuberculosis, particularly in the context of HIV co-infection.
Date
01 Jan 2018 - 31 Dec 2021
Project Type
GRANT
Keywords
Mycobacterium Tuberculosis;HIV;Vaccine Development;Immunology;Infectious Disease
Funding Body
National Health and Medical Research Council (NHMRC)
Amount
437034
Project Team
N/A